Caris Life Sciences Inc (CAI)

Date: O: H: L: C: Vol:

Finanzdaten der Caris Life Sciences Inc-Aktie (CAI)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	21.99%263.71	216.17	292.89	216.83	181.40
	3.33%32.36	31.32	31.85	21.62	25.05
Research and Development	3.33%32.36	31.32	31.85	21.62	25.05
Costs And Expenses	12.28%236.79	210.89	204.48	184.19	199.39
Operating Income/Loss	409.77%26.93	5.28	88.41	32.64	-17.99
Nonoperating Income/Loss	364.73%-27.54	-5.93	-6.45	-8.32	-53.80
Income/Loss From Continuing Operations Before Tax	4.66%-0.61	-0.64	81.96	24.33	-71.79
Income Tax Expense/Benefit	117.16%0.02	-0.13	-	-	-
	24.90%-0.64	-0.51	81.96	24.33	-71.79
Attributable To Parent	24.90%-0.64	-0.51	81.96	24.33	-71.79
Available To Common Stockholders, Basic	24.90%-0.64	-0.51	81.96	24.33	-517.20
Basic Average Shares	0.12%282.89	282.56	-	282.10	64.92
Diluted Average Shares	0.12%282.89	282.56	-	297.21	64.92
Basic Earnings Per Share	-	-	-	0.09	-7.97
Diluted Earnings Per Share	-	-	-	0.08	-7.97